BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24956745)

  • 1. [Impact of 131I SPECT/CT on the management of differentiated thyroid carcinoma outpatients with radioablation].
    Mizokami D; Kosuda S; Shiotani A; Kinoshita F; Saotome K; Morozumi K
    Nihon Jibiinkoka Gakkai Kaiho; 2014 May; 117(5):673-80. PubMed ID: 24956745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of 131I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation.
    Schmidt D; Szikszai A; Linke R; Bautz W; Kuwert T
    J Nucl Med; 2009 Jan; 50(1):18-23. PubMed ID: 19091884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a
    Spanu A; Nuvoli S; Marongiu A; Gelo I; Mele L; Piras B; Madeddu G
    BMC Cancer; 2020 Mar; 20(1):239. PubMed ID: 32197595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five months' follow-up of patients with and without iodine-positive lymph node metastases of thyroid carcinoma as disclosed by (131)I-SPECT/CT at the first radioablation.
    Schmidt D; Linke R; Uder M; Kuwert T
    Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):699-705. PubMed ID: 19936746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of technetium-99m methoxyisobutylisonitrile scintigraphy in the planning of therapy and follow-up of patients with differentiated thyroid carcinoma after surgery.
    Rubello D; Mazzarotto R; Casara D
    Eur J Nucl Med; 2000 Apr; 27(4):431-40. PubMed ID: 10805117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of Diagnostic
    Spanu A; Nuvoli S; Gelo I; Mele L; Piras B; Madeddu G
    J Nucl Med; 2018 Oct; 59(10):1510-1515. PubMed ID: 29496990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of single-photon emission computed tomography/computed tomography of the neck and thorax in postablation (131)I scintigraphy for thyroid cancer.
    Aide N; Heutte N; Rame JP; Rousseau E; Loiseau C; Henry-Amar M; Bardet S
    J Clin Endocrinol Metab; 2009 Jun; 94(6):2075-84. PubMed ID: 19276233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incremental value of 131I SPECT/CT in the management of patients with differentiated thyroid carcinoma.
    Chen L; Luo Q; Shen Y; Yu Y; Yuan Z; Lu H; Zhu R
    J Nucl Med; 2008 Dec; 49(12):1952-7. PubMed ID: 18997044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incremental diagnostic value of SPECT/CT with 131I scintigraphy after radioiodine therapy in patients with well-differentiated thyroid carcinoma.
    Maruoka Y; Abe K; Baba S; Isoda T; Sawamoto H; Tanabe Y; Sasaki M; Honda H
    Radiology; 2012 Dec; 265(3):902-9. PubMed ID: 23012466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging.
    Spanu A; Solinas ME; Chessa F; Sanna D; Nuvoli S; Madeddu G
    J Nucl Med; 2009 Feb; 50(2):184-90. PubMed ID: 19164225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99m-pertechnetate whole-body SPET/CT scan in thyroidectomized differentiated thyroid cancer patients is a useful imaging modality in detecting remnant thyroid tissue, nodal and distant metastases before
    Lou K; Gu Y; Hu Y; Wang S; Shi H
    Hell J Nucl Med; 2018; 21(2):121-124. PubMed ID: 30089313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ¹³¹I whole-body imaging, ¹³¹I SPECT/CT, and ¹⁸F-FDG PET/CT in the detection of metastatic thyroid cancer.
    Oh JR; Byun BH; Hong SP; Chong A; Kim J; Yoo SW; Kang SR; Kim DY; Song HC; Bom HS; Min JJ
    Eur J Nucl Med Mol Imaging; 2011 Aug; 38(8):1459-68. PubMed ID: 21505897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiated thyroid carcinoma: Incremental diagnostic value of
    Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
    Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
    de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
    Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of (99m)Tc-pertechnetate whole body scan with neck and chest SPECT/CT for detection of post-surgical thyroid remnant and metastasis in differentiated thyroid cancer patients.
    Chantadisai M; Kingpetch K
    Ann Nucl Med; 2014 Aug; 28(7):674-82. PubMed ID: 24889127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Double-phase (131)I whole body scan and (131)I SPECT-CT images in patients with differentiated thyroid cancer: their effectiveness for accurate identification.
    Wakabayashi H; Nakajima K; Fukuoka M; Inaki A; Nakamura A; Kayano D; Kinuya S
    Ann Nucl Med; 2011 Nov; 25(9):609-15. PubMed ID: 21725630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma.
    Tharp K; Israel O; Hausmann J; Bettman L; Martin WH; Daitzchman M; Sandler MP; Delbeke D
    Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1435-42. PubMed ID: 15221294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. I-131 SPECT/CT elucidates cryptic findings on planar whole-body scans and can reduce needless therapy with I-131 in post-thyroidectomy thyroid cancer patients.
    Blum M; Tiu S; Chu M; Goel S; Friedman K
    Thyroid; 2011 Nov; 21(11):1235-47. PubMed ID: 22007920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High Level of Agreement Between Pretherapeutic 124I PET and Intratherapeutic 131I Imaging in Detecting Iodine-Positive Thyroid Cancer Metastases.
    Ruhlmann M; Jentzen W; Ruhlmann V; Pettinato C; Rossi G; Binse I; Bockisch A; Rosenbaum-Krumme S
    J Nucl Med; 2016 Sep; 57(9):1339-42. PubMed ID: 27151981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up of differentiated thyroid cancer: what is the value of FDG and sestamibi in the diagnostic algorithm?
    Dietlein M; Scheidhauer K; Voth E; Theissen P; Schicha H
    Nuklearmedizin; 1998 Jan; 37(1):12-7. PubMed ID: 9467164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.